Pages that link to "Q46917099"
Jump to navigation
Jump to search
The following pages link to Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel (Q46917099):
Displaying 4 items.
- Trial Watch-Immunostimulation with cytokines in cancer therapy (Q28078725) (← links)
- Gene interference strategies as a new tool for the treatment of prostate cancer (Q38518046) (← links)
- Anacardic acid induces cell apoptosis of prostatic cancer through autophagy by ER stress/DAPK3/Akt signaling pathway (Q42838192) (← links)
- Promising immunotherapy for prostate cancer (Q47566793) (← links)